141 related articles for article (PubMed ID: 271684)
21. McArdle's disease with non-insulin-dependent diabetes mellitus: the beneficial effects of hyperglycemia and hyperinsulinemia for exercise intolerance.
Yamauchi A; Amano K; Ichikawa Y; Nakamoto S; Takei I; Maruyama H; Kono N; Saruta T
Intern Med; 1996 May; 35(5):403-6. PubMed ID: 8797056
[TBL] [Abstract][Full Text] [Related]
22. McArdle's disease with late-onset symptoms: case report and review of the literature.
Felice KJ; Schneebaum AB; Jones HR
J Neurol Neurosurg Psychiatry; 1992 May; 55(5):407-8. PubMed ID: 1602316
[TBL] [Abstract][Full Text] [Related]
23. McArdle's syndrome. Fine structural changes in muscle.
Korényi-Both A; Smith BH; Baruah JK
Acta Neuropathol; 1977 Sep; 40(1):11-9. PubMed ID: 269622
[TBL] [Abstract][Full Text] [Related]
24. The second wind phenomenon in McArdle's disease.
Braakhekke JP; de Bruin MI; Stegeman DF; Wevers RA; Binkhorst RA; Joosten EM
Brain; 1986 Dec; 109 ( Pt 6)():1087-101. PubMed ID: 3466659
[TBL] [Abstract][Full Text] [Related]
25. Muscle fatigue in McArdle's disease studied by 31P-NMR: effect of glucose infusion.
Lewis SF; Haller RG; Cook JD; Nunnally RL
J Appl Physiol (1985); 1985 Dec; 59(6):1991-4. PubMed ID: 3865926
[TBL] [Abstract][Full Text] [Related]
26. Research on molecular mechanisms of McArdle's disease (muscle glycogen phosphorylase deficiency). Use of new protein mapping and immunological techniques.
Daegelen-Proux D; Kahn A; Marie J; Dreyfus JC
Ann Hum Genet; 1981 May; 45(2):113-20. PubMed ID: 6797345
[TBL] [Abstract][Full Text] [Related]
27. [Glycogenosis type V of adults: muscle phosphorylase deficiency].
Coll Cantí J; Illa I; Beleta J; Anglada A; Pradas J; González Sastre F; Grau Veciana JM; Gella FJ
Med Clin (Barc); 1986 Mar; 86(8):335-8. PubMed ID: 3458989
[No Abstract] [Full Text] [Related]
28. Low muscle levels of pyridoxine in McArdle's syndrome.
Haller RG; Dempsey WB; Feit H; Cook JD; Knochel JP
Am J Med; 1983 Feb; 74(2):217-20. PubMed ID: 6572033
[TBL] [Abstract][Full Text] [Related]
29. McArdle's disease heterozygotes. Metabolic adaptation assessed using 31P-nuclear magnetic resonance.
Bogusky RT; Taylor RG; Anderson LJ; Angelos KL; Lieberman JS; Walsh DA
J Clin Invest; 1986 Jun; 77(6):1881-7. PubMed ID: 3458722
[TBL] [Abstract][Full Text] [Related]
30. [McArdle's disease. Clinical, electromyographic and histological studies of the 1st case reported in Japan].
Itoyama Y; Santa T; Shibasaki H; Goto I; Kuroiwa Y
Rinsho Shinkeigaku; 1975 Jul; 15(7):450-7. PubMed ID: 1059511
[No Abstract] [Full Text] [Related]
31. Impairment of sympathetic activation during static exercise in patients with muscle phosphorylase deficiency (McArdle's disease).
Pryor SL; Lewis SF; Haller RG; Bertocci LA; Victor RG
J Clin Invest; 1990 May; 85(5):1444-9. PubMed ID: 2332499
[TBL] [Abstract][Full Text] [Related]
32. Ischemic exercise test: failure to detect partial expression of McArdle's disease.
Taylor RG; Lieberman JS; Portwood MM
Muscle Nerve; 1987; 10(6):546-51. PubMed ID: 3476851
[TBL] [Abstract][Full Text] [Related]
33. [McArdle's syndrome].
Ebbesen F; Brandt NJ; Lochte J
Ugeskr Laeger; 1977 Nov; 139(47):2805-8. PubMed ID: 271415
[No Abstract] [Full Text] [Related]
34. Breakdown of adenine nucleotide pool in fatiguing skeletal muscle in McArdle's disease: a noninvasive 31P-MRS and EMG study.
Zange J; Grehl T; Disselhorst-Klug C; Rau G; Müller K; Schröder R; Tegenthoff M; Malin JP; Vorgerd M
Muscle Nerve; 2003 Jun; 27(6):728-36. PubMed ID: 12766985
[TBL] [Abstract][Full Text] [Related]
35. 2,4-Dinitrophenol, muscle biopsy, and McArdle's disease.
Heller SL; Brooke MH; Kaiser KK; Choski R
Neurology; 1988 Jan; 38(1):15-9. PubMed ID: 3422109
[TBL] [Abstract][Full Text] [Related]
36. HyperCKemia as the only sign of McArdle's disease in a child.
Bruno C; Bertini E; Santorelli FM; DiMauro S
J Child Neurol; 2000 Feb; 15(2):137-8. PubMed ID: 10695902
[TBL] [Abstract][Full Text] [Related]
37. [McArdle's disease. Apropos of a case].
Yuste JR; Beloqui O; De la Peña A; Rodríguez-Rosado R; Monreal JI; Prósper F; Prieto J
Rev Med Univ Navarra; 1998; 42(1):29-33. PubMed ID: 10420954
[TBL] [Abstract][Full Text] [Related]
38. Molecular mechanisms of McArdle's disease (muscle glycogen phosphorylase deficiency). RNA and DNA analysis.
Gautron S; Daegelen D; Mennecier F; Dubocq D; Kahn A; Dreyfus JC
J Clin Invest; 1987 Jan; 79(1):275-81. PubMed ID: 3466902
[TBL] [Abstract][Full Text] [Related]
39. Late-onset McArdle's disease mimicking treatment-resistant polymyositis. Report of a case and review of the literature.
Pego R; González-Gay MA; García-Porrúa C; Brañas F; Navarro C
Rev Rhum Engl Ed; 1999 Apr; 66(4):236-7. PubMed ID: 10339783
[No Abstract] [Full Text] [Related]
40. Asymptomatic McArdle's disease associated with hyper-creatine kinase-emia and absence of myophosphorylase.
Gospe SM; El-Schahawi M; Shanske S; Bruno C; DiMauro S; Hoye E; Walsh DA; Gorin FA
Neurology; 1998 Oct; 51(4):1228-9. PubMed ID: 9781574
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
